Dashboard
Manage Tickers

IMAX IMAX CORP

NYSE imax.com


$ 33.55 $ 1.03 (3.17 %)    

Wednesday, 05-Nov-2025 15:59:59 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 622.38 $ 4.94 (0.8 %)
DIA $ 473.04 $ 2.23 (0.47 %)
SPY $ 677.28 $ 2.47 (0.37 %)
TLT $ 89.01 $ -0.57 (-0.64 %)
GLD $ 365.20 $ 0.10 (0.03 %)
$ 33.56
$ 32.61
$ 31.63 x 10
$ 34.29 x 3
$ 32.34 - $ 33.64
$ 20.48 - $ 34.14
1,466,045
na
1.81B
$ 0.72
$ 45.66
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-23-2025 09-30-2025 10-Q
2 07-24-2025 06-30-2025 10-Q
3 04-23-2025 03-31-2025 10-Q
4 02-19-2025 12-31-2024 10-K
5 10-30-2024 09-30-2024 10-Q
6 07-25-2024 06-30-2024 10-Q
7 04-25-2024 03-31-2024 10-Q
8 02-27-2024 12-31-2023 10-K
9 10-25-2023 09-30-2023 10-Q
10 07-26-2023 06-30-2023 10-Q
11 04-27-2023 03-31-2023 10-Q
12 02-22-2023 12-31-2022 10-K
13 10-31-2022 09-30-2022 10-Q
14 07-28-2022 06-30-2022 10-Q
15 04-28-2022 03-31-2022 10-Q
16 02-23-2022 12-31-2021 10-K
17 10-28-2021 09-30-2021 10-Q
18 07-27-2021 06-30-2021 10-Q
19 04-29-2021 03-31-2021 10-Q
20 03-04-2021 12-31-2020 10-K
21 10-29-2020 09-30-2020 10-Q
22 07-28-2020 06-30-2020 10-Q
23 04-30-2020 03-31-2020 10-Q
24 02-19-2020 12-31-2019 10-K
25 10-31-2019 09-30-2019 10-Q
26 07-30-2019 06-30-2019 10-Q
27 04-26-2019 03-31-2019 10-Q
28 02-26-2019 12-31-2018 10-K
29 10-25-2018 09-30-2018 10-Q
30 07-25-2018 06-30-2018 10-Q
31 05-01-2018 03-31-2018 10-Q
32 02-27-2018 12-31-2017 10-K
33 10-26-2017 09-30-2017 10-Q
34 07-26-2017 06-30-2017 10-Q
35 04-20-2017 03-31-2017 10-Q
36 02-23-2017 12-31-2016 10-K
37 10-20-2016 09-30-2016 10-Q
38 07-20-2016 06-30-2016 10-Q
39 04-21-2016 03-31-2016 10-Q
40 02-24-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

imax-moves-to-reduce-dilution-with-new-convertible-offering
IMAX Moves To Reduce Dilution With New Con...
11/04/2025 10:39:11

IMAX Corp prices $220 million of convertible senior notes due 2030 for qualified institutional buyers, with option for addition...

imax-prices-220m-075-convertible-notes-due-2030-to-refinance-2026-notes-and-strengthen-balance-sheet
IMAX Prices $220M 0.75% Convertible Notes ...
11/04/2025 06:59:10

Opportunistic capital raise for the substantial refinancing of outstanding 2026 notesIMAX to purchase capped calls intended to ...

imax-to-offer-220m-in-convertible-senior-notes-due-2030-30m-upsize-option-included
IMAX To Offer $220M In Convertible Senior ...
11/03/2025 11:50:26

Opportunistic capital raise for the partial refinancing of outstanding 2026 notes, working capital, share repurchases or other ...

Core News & Articles
IMAX, Cinemark Sign Agreement To Launch Ne...
10/27/2025 12:41:36

IMAX Corporation (NYSE: IMAX) and Cinemark Holdings Inc. today announced an agreement spanning 17 Cinemark locations in the Uni...

barrington-research-maintains-outperform-on-imax-maintains-37-price-target
Barrington Research Maintains Outperform o...
10/24/2025 21:32:00

Barrington Research analyst Patrick Sholl maintains Imax (NYSE:IMAX) with a Outperform and maintains $37 price target.

wells-fargo-maintains-overweight-on-imax-raises-price-target-to-40
Wells Fargo Maintains Overweight on Imax, ...
10/24/2025 14:14:18

Wells Fargo analyst Omar Mejias maintains Imax (NYSE:IMAX) with a Overweight and raises the price target from $34 to $40.

jp-morgan-maintains-neutral-on-imax-raises-price-target-to-32
JP Morgan Maintains Neutral on Imax, Raise...
10/24/2025 13:06:01

JP Morgan analyst David Karnovsky maintains Imax (NYSE:IMAX) with a Neutral and raises the price target from $31 to $32.

rosenblatt-maintains-buy-on-imax-maintains-42-price-target
Rosenblatt Maintains Buy on Imax, Maintain...
10/24/2025 11:36:13

Rosenblatt analyst Steve Frankel maintains Imax (NYSE:IMAX) with a Buy and maintains $42 price target.

barrington-research-maintains-outperform-on-imax-maintains-37-price-target
Barrington Research Maintains Outperform o...
10/23/2025 16:27:28

Barrington Research analyst Patrick Sholl maintains Imax (NYSE:IMAX) with a Outperform and maintains $37 price target.

imax-crushes-earnings-defying-a-slumping-hollywood-box-office
IMAX Crushes Earnings, Defying A Slumping ...
10/23/2025 15:10:32

IMAX (NYSE: IMAX) stock jumps on Q3 financial results, including record-breaking box office and strong global expansion. CEO pr...

imax-q3-adj-eps-047-beats-038-estimate-sales-106654m-beat-105155m-estimate
Imax Q3 Adj. EPS $0.47 Beats $0.38 Estimat...
10/23/2025 11:31:15

Imax (NYSE:IMAX) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.38 by 23.04 per...

Core News & Articles
Earnings Scheduled For October 23, 2025
10/23/2025 08:32:24

an-overview-of-imaxs-earnings
An Overview of Imax's Earnings
10/22/2025 21:03:54

roth-capital-maintains-buy-on-imax-raises-price-target-to-40
Roth Capital Maintains Buy on Imax, Raises...
10/14/2025 16:54:03

Roth Capital analyst Eric Handler maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $36 to $40.

disneys-tron-ares-stumbles-can-zootopia-2-avatar-3-help-end-2025-with-hits
Disney's 'Tron: Ares' Stumbles: Can Zootop...
10/13/2025 20:00:59

Disney has had multiple box office disappointments in 2025, but could have its biggest hits of the year still to come.

assessing-imax-insights-from-10-financial-analysts
Assessing Imax: Insights From 10 Financial...
10/09/2025 21:01:17

rosenblatt-maintains-buy-on-imax-raises-price-target-to-42
Rosenblatt Maintains Buy on Imax, Raises P...
10/09/2025 16:21:39

Rosenblatt analyst Steve Frankel maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $37 to $42.

jp-morgan-maintains-neutral-on-imax-raises-price-target-to-31
JP Morgan Maintains Neutral on Imax, Raise...
10/09/2025 13:06:20

JP Morgan analyst David Karnovsky maintains Imax (NYSE:IMAX) with a Neutral and raises the price target from $28 to $31.

barrington-research-maintains-outperform-on-imax-maintains-37-price-target
Barrington Research Maintains Outperform o...
09/23/2025 15:12:48

Barrington Research analyst Patrick Sholl maintains Imax (NYSE:IMAX) with a Outperform and maintains $37 price target.

local-language-hits-are-driving-imax-profits-analysts
Local-Language Hits Are Driving IMAX Profi...
09/22/2025 17:44:56

IMAX (NYSE: IMAX) expected to grow with strong global releases, higher demand, and new screens. Wedbush raises price forecast t...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION